DP3

Dược phẩm Trung ương 3 ·HNX ·2026Q1

▲▲ Improving positively

Operating efficiency is improving Net margin 34.19%, +3.87pp YoY
Price
58,600
Latest close
02 Jun 2026
P/E 7.66x
P/B 1.95x
EPS 7,651
BVPS 30,011
ROE 27.7%
ROA 22.8%
Profit Margin 34.2%
Asset Turnover 0.67x
Equity Mult. 1.22x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, DP3 has not accelerated revenue sharply, but profitability is improving visibly — profit is at an all-time high. Profit growth is driven mainly by better operations rather than scale expansion — a foundation that tends to be more durable.

TTM REVENUE
VND 481bn
+18.6%YoY
NET MARGIN
34.19%
+3.9ppYoY
TTM NET PROFIT
VND 164bn
+33.7%YoY
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 135.0 131.6 120.2 94.2 91.9 116.2 95.2 102.4 103.7 98.0 91.1 100.9
Growth +3% +9% +28% +3% -21% +22% -7% -1% +6% +8% -10%
Net Income 34.8 74.6 23.0 32.1 23.9 50.1 21.3 27.7 22.0 50.5 18.9 31.6
Net Margin 25.76% 56.65% 19.15% 34.06% 25.97% 43.12% 22.37% 27.08% 21.26% 51.57% 20.71% 31.33%

Drivers of DP3's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by higher gross profit. Supporting and offsetting drivers:

Gross profit ↑ 55.7bn
Financial income ↑ 8.4bn
Tax ↑ 10.8bn
Selling expenses ↑ 9.9bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by higher gross profit. Supporting and offsetting drivers:

Gross profit ↑ 34.2bn
Financial income ↑ 1.2bn
Selling expenses ↑ 20.0bn
Tax ↑ 2.7bn
Administrative expenses ↑ 1.2bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 23.8% = 30.3% × 0.67 × 1.18
2026Q1 27.7% = 34.2% × 0.67 × 1.22

ROE rose from 23.8% to 27.7% — mainly driven by leverage, despite asset turnover moving in the opposite direction.

Net margin: 34.2% +3.9pp Asset turnover: 0.67x -0.00x Leverage: 1.22x +0.04x

Is the profit sustainable?

Margins are improving and earnings quality is solid — a durable foundation for ROE.

very positive positive stable watch under pressure

What is driving the margin?

Net margin expanded to 34.19%, rising 3.9pp. The main driver is SG&A / Revenue fell 2.6pp and Gross margin rose 1.3pp, moving in line with the stronger net margin (with additional support from Net financial result / Revenue rose 0.9pp).

The improvement comes from core operations — this is a high-quality margin expansion.

Profitability trend

Net Margin 34.19% +3.9pp
Gross Margin 66.91% +1.3pp
SG&A / Revenue 28.76% −2.6pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Return on capital rose, but cash cycle lengthened by 4.8 days — working capital needs watching.

Is capital being deployed efficiently?

ROIC expanded to 26.65%, rising 3.0pp. That translates to 26.65 in after-tax operating profit for every 100 units of operating capital. The main driver is NOPAT margin rose 3.8pp, with capital turnover broadly stable; while invested capital rose by 96bn.

Capital efficiency improved through NOPAT margin — this is a quality-led improvement when operating profit leads.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 26.65% +3.0pp
NOPAT Margin 34.15% +3.8pp
Capital Turnover 0.78x +0.00x
Average Invested Capital 616.5bn +95.8bn

Balance Sheet

ROIC is improving — the asset structure below shows how capital is being allocated. Capital structure is conservative with low leverage — liabilities at 0.24x equity, net debt at 0.05x equity.

Over the last 12 months, working capital released 0.0bn of cash.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables were broadly stable → neutral CFO:
Inventories were broadly stable → neutral CFO:
Payables were broadly stable → neutral CFO:

Working Capital Efficiency

Cash conversion cycle lengthened by 4.8 days versus the same period last year. The main moves came from DIO fell 3.2 days, DSO rose 2.2 days, and DPO fell 5.8 days.

Working capital cycle lengthened mainly due to shorter payment timing — may reflect pressure from suppliers.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 133.3 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +2.2 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 36.2 days +2.2 days
Inventory 134.1 days −3.2 days
Payables 37.0 days −5.8 days
Cash Conversion Cycle 133.3 days +4.8 days

Is financial risk significant?

Check leverage, liquidity, and cash-flow conversion.

Leverage & Liquidity

Leverage looks fairly comfortable, with net debt / equity at 0.05x and interest coverage at 161.37x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 11.3% of debt, and total debt stands at 32.8bn.

Watchpoints

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Cash buffer is thin relative to debt

Cash / debt stands at 11.3%, leaving limited liquidity buffer to monitor.

Leverage and liquidity trend

Net Debt / Equity 0.05x +0.02x
Interest Coverage 161.37x −365.68x
Cash / Debt 11.3% +0.7pp
Short-term Debt / Total Debt 100.0% 0.0pp
CFO / NI 1.11x +0.03x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 151.5bn in 2025, against investing cash flow of -130.6bn.

Post-investment cash flow was positive +20.9bn. Financing cash flow was negative +30.2bn.

CFO / net income was 1.11x.

Track how much investment can be funded internally from operating cash flow.

Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 182.0bn +49.4bn
Cash Capex
FCF TTM

Investment Takeaway

The business is entering a broader improvement phase — not just stronger earnings but better operating quality as well. Margin, ROIC, and cash flow all improving shows the business is growing in a cleaner and more efficient way than before. Notably, the improvement trend has been confirmed across multiple cycles, from margin to capital efficiency and cash generation. Even so, cash generation still needs confirmation remains the area to verify in upcoming periods. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 133 days.

Improvement: operating efficiency is getting better, with trailing-12M net margin at 34.19% after expanding 3.9pp versus the same period last year.

Watchpoint: Cash generation still needs confirmation.

Key risk: working capital remains tied up for too long, with cash cycle at 133.3 days.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
437.9 417.5 409.7 485.1 381.1
Cost of Goods Sold
150.3 141.4 128.2 148.5 0.0
Gross Profit
287.6 276.1 281.5 336.5 263.6
Financial Expenses
0.8 0.3 1.9 2.2 -1.4
Selling Expenses
77.9 94.1 74.2 135.1 -95.5
General and Administrative Expenses
39.4 45.3 70.4 73.7 -56.0
Operating Profit
192.3 151.8 156.6 136.4 118.1
Profit Before Tax
192.6 151.9 157.0 136.5 118.2
Net Income
156.1 121.2 125.3 108.8 94.3
Profit Attributable to Parent
156.1 121.2 125.3 108.8 94.3
Earnings per Share
7,259.00 5,636.00 5,826.00 12,021.00 10,965.00

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.